---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-25-000022"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-23T00:58:26.448652+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q1 net loss $13M includes $31M EO settlement; Adj EBITDA up 8.8%

## Summary
- Net revenues $255M, up 2.6% YoY (4.4% constant currency). Sterigenics segment $170M.
- Net loss $13M ($0.05 diluted loss) vs net income $6M ($0.02) in Q1 2024; includes $31M EO settlement charge.
- Adjusted EBITDA $122M, up 8.8% (11.2% constant currency). Adjusted EPS $0.14 vs $0.13.
- Company reaffirms FY2025 constant-currency outlook: 4-6% net revenue growth, 4.5-6.5% Adj EBITDA growth.

## SEC filing metadata
- accession: 0001822479-25-000022
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247925000022/0001822479-25-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247925000022/shc-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-25-000022
- JSON: https://secwatch.observer/filing/0001822479-25-000022.json
- Plain text: https://secwatch.observer/filing/0001822479-25-000022.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.